Other Events ·
Park Ha Biological Technology shareholders approve increasing authorized capital to US$300M and boosting Class B voting rights to 100 per share
BYAHPark Ha Biological Technology Co., Ltd.
Park Ha Biological Technology Co., Ltd. announced the successful passage of all resolutions at its Extraordinary General Meeting and Class A Meeting held on July 13, 2026. Shareholders approved increasing the company's authorized share capital from US$3,000,000 to US$300,000,000 by creating 297,000,000,000 additional ordinary shares. The Board was authorized to execute share consolidations (2-for-1 to 5,000-for-1) and subdivisions (2-for-1 to 100-for-1) over the next three years. Additionally, a special resolution was passed to increase the voting rights of Class B Ordinary Shares from 20 votes to 100 votes per share. The company operates in the biotechnology industry.